Whiting A A - OmicsDI

Show results for

Unknown (850)
Transcriptomics (15)
Genomics (14)
Proteomics (3)
Models (2)
Metabolomics (1)

Organisms

Homo sapiens (14)
Alphavirus (3)
Anemia (3)
Archaea (3)
Bacteria (3)
Betaherpesvirinae (3)
Borrelia (3)
Clostridium perfringens (3)
Cowpox virus (3)
Cytomegalovirus (3)
Dengue virus (3)
Eukaryota (3)
Hepatitis B virus (3)
Human alphaherpesvirus 1 (3)
Human betaherpesvirus 5 (3)
Human immunodeficiency virus (3)
Influenza A virus (3)
Influenza C virus (3)
Japanese encephalitis virus group (3)
Kamptonema sp. (3)
Listeria monocytogenes (3)
Mammarenavirus (3)
Miscanthus x giganteus (3)
Mycobacterium tuberculosis (3)
Rattus (3)
Sarbecovirus (3)
Severe acute respiratory syndrome coronavirus 2 (3)
cellular organisms (1)
Gallus gallus (1)
Mus musculus (1)

Organisms

Natator depressus (3)
Gentiana scabra var. buergeri (1)
lake water metagenome (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (14)
ENA (14)
pride (3)
BioModels (2)
geo (1)
MetaboLights (1)

Tissue

Blood plasma (2)
Colon (1)
Vesicle membrane (1)

Disease

Colon cancer (1)
Non-small cell lung carcinoma (1)

Technology Type

Mass Spectrometry (3)
Shotgun proteomics (2)
Mass spectrometry (1)
SWATH MS (1)

Instrument Platform

NextSeq 550 (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2011 (6)
2024 (2)
2022 (2)
2015 (2)
2012 (2)
2005 (1)
2020 (1)
2014 (1)
2013 (1)
2021 (1)
2025 (1)
2018 (1)

UNIPROT ID/AC

P10276 (1)

CHEBI ID

CHEBI:42492 (1)
CHEBI:15367 (1)
CHEBI:16670 (1)
CHEBI:185590 (1)
CHEBI:185033 (1)
CHEBI:185082 (1)
CHEBI:184433 (1)
CHEBI:185588 (1)
CHEBI:185586 (1)
CHEBI:185161 (1)
CHEBI:185584 (1)
CHEBI:184906 (1)
CHEBI:185183 (1)
CHEBI:185582 (1)
CHEBI:185580 (1)
CHEBI:184474 (1)
CHEBI:184829 (1)
CHEBI:185175 (1)
CHEBI:184782 (1)
CHEBI:185578 (1)
CHEBI:184420 (1)
CHEBI:185576 (1)
CHEBI:184776 (1)
CHEBI:184405 (1)
CHEBI:185575 (1)
CHEBI:185573 (1)
CHEBI:185571 (1)
CHEBI:185568 (1)
CHEBI:185013 (1)
CHEBI:185567 (1)

Metabolite Name

PS(DIME(11,5)/MONOME(13,5)) (1)
4,4,10-Trimethyl-1,11-bis(3-methylbut-2-en-1-yl)-10-(4-methylpent-3-en-1-yl)-9-(2-methylpropanoyl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione (1)
2-{[3,4-dihydroxy-5,6-bis({[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxy})oxan-2-yl]methoxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate (1)
{2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-3-(tetracosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid (1)
TG(20:1(11Z)/22:2(13Z,16Z)/20:2(11Z,14Z)) (1)
1-(8-{[6-({[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxy-6-methoxy-3-methylnaphthalen-2-yl)ethan-1-one (1)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({[3-(methylsulfanyl)propyl]thio(carbonoimidyl)}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid (1)
(2E)-N-{2-[5,5'-dihydroxy-3'-(2-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}ethyl)-1H,1'H-[4,4'-biindole]-3-yl]ethyl}-3-(4-hydroxyphenyl)prop-2-enimidic acid (1)
(2R,3R)-2-(3,4-Dihydroxyphenyl)-6-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2H-1-benzopyran-4-yl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (1)
2-(Hydroxymethyl)-6-[(3,4,5-trihydroxy-6-{[16-hydroxy-2,6,6,10,11-pentamethyl-14-(6-methyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}oxan-2-yl)methoxy]oxane-3,4,5-triol (1)
6-(16'-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-15'-oloxy)-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
3-[({2-[(3-{[4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)carbonyl]-4-hydroxy-4-phenylbutanoic acid (1)
PC(O-22:1(13Z)/22:2(13Z,16Z)) (1)
4-({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(11E)-icos-11-enoylsulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid (1)
(1R,2R,3R,11S,12S,14R,26R)-5,6',7',12-tetrahydroxy-6-methoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1³,¹¹.0²,¹³.0⁴,⁹.0¹⁵,²³.0¹⁶,²⁰]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate (1)
Ps(14:1(9z)/20:5(5z,8z,11z,14z,17z)) (1)
2-[6'-(5,7-Dihydroxy-4-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-2-yl)-2',3',4,4',5,6-hexahydroxy-[1,1'-biphenyl]-2-yl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (1)
Heptacosane-6,8-dione (1)
3,4,5-trihydroxy-6-{[5-hydroxy-14-(1-hydroxy-6-methylhept-5-en-2-yl)-2,11,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-8-yl]oxy}oxane-2-carboxylic acid (1)
2-[(7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate (1)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (1)
2-[2-({7-[(3-carboxy-3-{2-[(6-carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-2-oxoethyl}propanoyl)oxy]-11,16,18-trihydroxy-19-[(1-hydroxyethylidene)amino]-5,9-dimethylicosan-6-yl}oxy)-2-oxoethyl]butanedioic acid (1)
(6-{4-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-8-yl}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxidanesulfonic acid (1)
[6,7,8,11,12,13,23-heptahydroxy-3,16-dioxo-21-(3,4,5-trihydroxybenzoyloxy)-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10,12,14-hexaen-22-yl]oxidanesulfonic acid (1)
N-Isobutyl-2E,4Z-octadecadienoyl amine (1)
PA(O-16:0/18:0) (1)
(4,5-dihydroxy-2-{[(1E)-3-hydroxy-3-methyl-1-[(sulfooxy)imino]pentyl]sulfanyl}-6-(hydroxymethyl)oxan-3-yl)oxidanesulfonic acid (1)
{[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(14-methylpentadecanoyl)oxy]-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinic acid (1)
{4-[2-(3,5-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-5,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl}oxidanesulfonic acid (1)
(2S,15R)-14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-7-ylium-5-olate (1)

IsPrivate

False (2)

First Public Date

2025 (5)
2026 (3)
2022 (2)
2021 (2)
2024 (1)
2020 (1)

Modelling Approach

Ordinary differential equation model (2)

Study type

Transcription profiling by array (8)
Methylation profiling by array (4)
MicroRNA profiling by array (1)
RNA-seq of coding RNA (1)

Release Date

2022 (127)
2021 (107)
2024 (92)
2023 (90)
2025 (73)
2020 (71)
2019 (53)
2018 (44)
2017 (43)
2015 (28)
2016 (27)
2014 (23)
2011 (14)
2013 (11)
2012 (11)
2026 (10)
2010 (8)
2009 (8)
2008 (6)
2006 (6)
2005 (4)
2007 (3)
2004 (1)
2003 (1)
2002 (1)
2000 (1)
1999 (1)

Lab affiliation

Alzheimer’s Research UK UCL Drug Discovery Institute, University College London, Cruciform Building, Gower Street, London, WC1E 6BT, U.K. (1)
Instituto de Investiaciones Sanitarias de Santiago de Compostela (1)
National Institute for Biological Standards and Control (1)

885 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

IsPrivate

First Public Date

Modelling Approach

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets